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weakness. Examination of a Neb-deficient model suggests 
this mechanism may be common in nemaline myopa-
thy. Another subtype results from a reduction of actin and 
forms a more stable cytoplasmic body. In contrast, the final 
type originates at the Z-disk and is associated with myofi-
brillar disorganization. Analysis of zebrafish and muscle 
biopsies from ACTA1 nemaline myopathy patients demon-
strates that nemaline bodies also possess a different protein 
signature. In addition, we show that the ACTA1D286G muta-
tion causes impaired actin incorporation and localization in 
the sarcomere. Together these data provide a novel exami-
nation of nemaline body origins and dynamics in vivo and 
identifies pathological changes that correlate with muscle 
weakness.
Keywords Nemaline · Myopathy · Zebrafish · Actin · 
Protein aggregation
Introduction
Nemaline myopathy is a congenital skeletal muscle dis-
ease characterized by muscle weakness and low muscle 
tone, except in a few rare patients with hypertonia [20]. 
Severe nemaline myopathy results in death within the first 
Abstract Nemaline myopathy is characterized by muscle 
weakness and the presence of rod-like (nemaline) bodies. 
The genetic etiology of nemaline myopathy is becoming 
increasingly understood with mutations in ten genes now 
known to cause the disease. Despite this, the mechanism 
by which skeletal muscle weakness occurs remains elu-
sive, with previous studies showing no correlation between 
the frequency of nemaline bodies and disease severity. To 
investigate the formation of nemaline bodies and their role 
in pathogenesis, we generated overexpression and loss-
of-function zebrafish models for skeletal muscle α-actin 
(ACTA1) and nebulin (NEB). We identify three distinct 
types of nemaline bodies and visualize their formation in 
vivo, demonstrating these nemaline bodies not only exhibit 
different subcellular origins, but also have distinct patho-
logical consequences within the skeletal muscle. One sub-
type is highly dynamic and upon breakdown leads to the 
accumulation of cytoplasmic actin contributing to muscle 
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few months of life; however, individuals displaying milder 
forms are able to walk despite reduced muscle function 
[54]. Mutations in ten different genes cause nemaline myo-
pathy: skeletal muscle α-actin (ACTA1) [31], nebulin (NEB) 
[40], α-tropomyosin [24], β-tropomyosin [9], troponin T1 
[22], cofilin 2 (CFL2) [1], KBTBD13 [45], KLHL40 [43], 
KLHL41 [13] and leiomodin 3 (LMOD3) [58]. All of these 
genes either encode components of the thin filament or reg-
ulate thin filament organization and stability. NEB, which 
plays an important role in regulating thin filament length, 
is the most frequently affected gene in nemaline myopa-
thy with patients exhibiting muscle weakness and reduced 
force generation [37, 40]. Deletion of exon 55, causing a 
common form of autosomal recessive nemaline myopa-
thy [26], results in shortened thin filaments, alterations in 
cross-bridge cycling kinetics, and reduced calcium sensitiv-
ity [37, 38].
Nemaline myopathy patients present with a range of 
clinical phenotypes, but the presence of nemaline (rod-
shaped) bodies in skeletal muscles is the defining feature 
[30, 52]. These structures are thought to derive from the 
Z-disk and contain Z-disk proteins such as α-actinin [21, 
53], although nemaline bodies have also been described 
in the absence of Z-disk thickening [46]. While nemaline 
bodies are a hallmark of the disease, their frequency does 
not correlate with disease severity [3, 17, 28, 41, 42]. In 
addition, they are sometimes found at the myotendinous 
junction in healthy skeletal muscle [18, 27] and in healthy 
ocular muscles [39].
Mutations in ACTA1 account for ~25 % of nemaline 
myopathy cases and ~50 % of severe presentations [3]. 
The majority of ACTA1 patients carry a single, de novo, 
dominant mutation but approximately 10 % carry genetic 
or functional null mutations which are recessively inherited 
[25]. The dominant ACTA1D286G mutation produces a very 
severe form of nemaline myopathy [3, 12, 31]. In cell cul-
ture experiments, ACTA1D286G expression resulted in the 
formation of rod-like bodies [7, 49] and the mutant protein 
demonstrated reduced incorporation into sarcomeric struc-
tures [5]. Expression of ACTA1D286G in transgenic mice 
produced granulofilamentous accumulations in their skel-
etal muscle. These accumulations stained positive for both 
phalloidin (labeling F-actin) and α-actinin, and the mice 
displayed skeletal muscle weakness [41, 42]. Importantly, 
varying the proportion of mutant actin in this mouse model 
identified that disease severity correlated with the ratio of 
mutant to wild-type protein, suggesting a dominant nega-
tive action for ACTA1D286G [41].
To investigate the origin of nemaline bodies and to 
uncover the cause of skeletal muscle weakness, we devel-
oped overexpression and loss-of-function zebrafish mod-
els for ACTA1-related and a loss-of-function model for 
NEB-related nemaline myopathy. Remarkably, the in vivo 
examination of nemaline body formation and progression 
in Tg(ACTA1D286G-eGFP) fish demonstrates that nemaline 
bodies emanate from the myosepta and are dynamic and 
transitory in nature. We demonstrate that the breakdown of 
these early forming nemaline bodies coincides with the for-
mation of globular aggregates that sequester actin-binding 
proteins and correlates with reduced muscle activity. Con-
versely, we show that a reduction in α-actin produces a dis-
tinct type of Z-disk-derived nemaline body, which extends 
across the sarcomere, and causes the formation of cyto-
plasmic α-actinin-rich aggregates. These types of nemaline 
bodies contribute to impaired muscle function and myofi-
brillar disarray. From the examination of Neb knockdown 
fish, we suggest that disruption of α-actin stoichiometry 
may be a common mechanism of disease for nemaline 
myopathy. Finally, we also show that the ACTA1D286G 
mutation has impaired incorporation in the sarcomere, 




Fish maintenance and handling were carried out as per 
standard operating procedures approved by the Monash 
Animal Services Ethics Committee and the creation of 
transgenic lines approved by the School of Biological 
Sciences Animal Ethics Committee (BSCI/2011/18). For 
patient samples, all experiments were approved by the 
Children’s Hospital at Westmead Ethics Committee (CHW 
2005/042) and the Monash University Human Research 
Ethics Committee review panel (CF15/743-2015000336).
Production of transgenic constructs
Zebrafish were maintained as previously described [56]. 
Transgenic constructs were assembled with the modular 
tol2 kit [23]. C-terminal eGFP-tagged ACTA1 constructs 
were created using the following clones: p5E-Bact2, pME-
loxP-mCherry-pA-loxP (Genbank accession: KF753698), 
pME-iCre (Genbank accession: KF753697), pME-ACT-
A1D286G-EGFP, p3E-ACTA1D286G-EGFP (Biomatik), p3E-
ACTA1wildtype (Biomatik), p5E-actc1b [19], p3E-pA, pDEST-
Tol2-pA2 and pDEST-Tol2pA-cryaa:GFP [6]. Transgenic 
strains generated were Tg(βAct:loxP-mCherry-pA-loxP:Hs.
ACTA1_D286G-eGFP), Tg(βAct:loxP-mCherry-pA-
loxP:Hs.ACTA1-eGFP) and Tg(actc1b:iCre). Crossing of 
the Tg(actc1b:iCre) strain to either Tg(βAct:loxP-mCherry-
pA-loxP:Hs.ACTA1_D286G-eGFP) or Tg(βAct:loxP-
mCherry-pA-loxP:Hs.ACTA1-eGFP) results in the excision 
of the loxP-mCherry-pA-loxP cassette. The strains generated 
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from this cross are Tg(βAct:Hs.ACTA1_D286G-eGFP 
and Tg(βAct:Hs.ACTA1-eGFP) referred to hereafter as 
Tg(ACTA1D286G-eGFP) and Tg(ACTA1wildtype-eGFP), respec-
tively. For cardiac actin expression, the actc1a ORF was 
amplified by PCR from IMAGE clone 6893985 (Imagenes), 
fused to mCherry, and expressed using the actc1b promoter 
[15] cloned into the pDEST-Tol2-pA2 vector.
cDNA synthesis and quantitative RT‑PCR
Total RNA was extracted using TRI Reagent (Sigma). 
cDNA was synthesized by Superscript III Reverse Tran-
scriptase (Invitrogen Life Technologies). Quantitative 
RT-PCR (qRT-PCR) was performed using a Lightcycler 
(Roche) using SYBR Green Master mix (Roche). Primers 
used for RT-PCR analysis of morpholinos are listed in Sup-
plementary Table 1.
Gomori trichrome and immunohistochemistry staining
For Gomori trichrome staining on zebrafish tissues, 
50-h post-fertilization (hpf) embryos injected with 
actc1b;ACTA1D286G-eGFP were anesthetized and snap fro-
zen. Transverse sections (12 μm) were cut using a Leica 
CM 1850 cryostat. These were imaged for eGFP using a 
Zeiss Axiophot compound fluorescent microscope. Sections 
were then stained with modified Gomori trichrome and 
imaged using a Zeiss Axioskop 2 microscope. Fluorescent 
and Gomori stained images for the same section were then 
overlaid for analysis. For immunostaining on zebrafish tis-
sues, 4 % paraformaldehyde (PFA)-fixed 2 dpf whole-mount 
or 4 dpf vibratome-sectioned embryos were incubated 
for 10 min in 100 % acetone at −20 °C, washed 3 times 
in phosphate-buffered saline (PBS) with 0.02 % Tween 20 
(PBT), and then incubated for 7 min in trypsin and 3 min in 
4 % PFA. Tissues were then washed in PBT and incubated 
in blocking solution containing the appropriate primary anti-
body. Antibodies used were anti-α-actinin2 (Sigma clone 
A7811, 1:100), anti-GFP (Invitrogen A-11122), anti-GFP 
(DSHB clone 12A6), and AlexaFluor™-labeled-488 and 
AlexaFluor™-labeled-596 secondary antibodies (Molecu-
lar Probes, 1:200). The anti-α-actinin3 antibody was a kind 
gift of Prof Kathryn North (Murdoch Children’s Research 
Institute, Melbourne, Australia). The phalloidin used was 
rhodamine tagged (Molecular Probes, 1:200). Imaging was 
performed with a LSM 710 confocal microscope (Zeiss), 
and a 20× 1.0 numerical aperture water-dipping objective 
for time-lapse experiments or 63× 1.4 numerical aperture 
oil immersion objective for fixed specimens. All analyses 
used the ImageJ package Fiji [47].
For nemaline myopathy patient muscle biopsies [18], 
8 µm cryosections were collected on glass slides and 
stained either with Gomori trichrome as described [10] or 
with anti-α-actinin2 and phalloidin. Immunohistochem-
istry staining was performed as described [18]. In brief, 
following air drying, sections were blocked in 2 % BSA–
PBS for 15 min before being incubated in blocking solu-
tion containing the appropriate primary antibody for 16 h. 
The anti-α-actinin2 antibody was a kind gift of Prof Alan 
Beggs (Boston Children’s Hospital, Boston, USA, clone 
4B3, diluted 1:1000). The sections were then washed 3 
times in PBS and re-blocked for 15 min before being incu-
bated in AlexaFluor™-548 (Molecular Probes, 1:250) and 
AlexaFluor™-488-phalloidin (Molecular Probes, 1:40) 
for 1 h. Sections were mounted using Immu-Mount™ (cat 
#9990402, Thermo Scientific). All sections were imaged 
using a Zeiss Axioskop 2 microscope.
Electron microscopy (EM)
For EM 50 hpf, zebrafish embryos were anesthetized and 
immediately fixed in 2 % PFA/2 % glutaraldehyde in 0.1 M 
sodium cacodylate buffer (pH 7.5). Samples were post-
fixed in 1 % osmium, gradually dehydrated in ethanol, 
and embedded in Epon epoxy resin using a Pelco Biowave 
Pro. Ultrathin (90 nm) sagittal sections were cut using an 
Ultracut UCT ultramicrotome (Leica). For correlative light 
electron microscopy (CLEM), samples were initially fixed 
in 4 % paraformaldehyde (PFA)/0.4 % glutaraldehyde in 
0.1 M phosphate buffer (pH 7.4) to an equal volume of 
zebrafish embryo water for 10 min, followed by post-fix-
ation in 2 %PFA/0.2 % glutaraldehyde in 0.1 M phosphate 
buffer (pH 7.4) overnight at 4 °C. Processing of tissue 
for ultrathin cryosectioning was carried out as described 
[35]. For CLEM, the zebrafish were embedded in gelatin 
blocks and the blocks were infiltrated overnight with 2.3 M 
sucrose at 4 °C, mounted on aluminum pins, and frozen 
in liquid nitrogen. Sections were cut on an Ultracut UC7 
(Leica) and placed on 50 mesh hexagonal copper grids. 
The combined immunofluorescence labeling was carried 
out as described [51] using a biotinylated anti-eGFP anti-
body (1:300, Rockland #600-106-215), rabbit anti-biotin 
(1:10.000, Rockland #100-4198), and a goat anti-rabbit 
AlexaFluor™-488-labeled secondary antibody (Molecular 
Probes, 1:300). Fluorescence imaging was performed using 
a Leica AF6000LX Live cell microscope. EM images were 
taken using an 80 kV Hitachi S-7500 TEM equipped with a 
Gatan Multiscan digital camera.
Fluorescence recovery after photobleaching (FRAP) 
experiments
Two-day-old embryos expressing either ACTA1D286G-
eGFP or ACTA1wildtype-eGFP were anesthetized in 0.16 % 
tricaine methanesulfonate and laterally mounted in 1 % 
low melting agarose. Imaging was carried out on a LSM 
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710 confocal microscope (Zeiss) equipped with a 20× 1.0 
numerical aperture water-dipping objective and a 488-nm 
laser. A precise region of the muscle fiber was bleached 
with four iterations of 100 % laser and imaged every 20 s 
for 10 min after bleaching. Four images were taken prior 
to bleaching and averaged to obtain the pre-bleach value. 
Fiji [47] was used to determine fluorescence intensity of 
bleached and unbleached areas at each time point. FRAP 
data analysis was carried out as previously described [55].
Morpholino analysis
Morpholino antisense oligonucleotides (MOs) targeted 
against nebulin (exon 5 MO: 5′ TACAGTTCATACCT-
CACTTAGCTGC, exon 35 MO: 5′ GTCAGTATAGGAAT-
CATACCTGGCT), actc1b exon 2 (ex 2) MO (5′ TGCAGT-
GTTTTTTTCACCTGGTGAC) and actc1b 5′ UTR MO (5′ 
GGTCAAGTTGTTATCACAAGACTGA) (Gene Tools) 
were diluted in distilled water and co-injected with Cas-
cade Blue-labeled dextran (Molecular Probes) into one- to 
four-cell embryos at a final concentration of 0.5 μM. The 
embryos were sorted for Cascade Blue labeling prior to 
analysis.
Western blot analysis
100 μg of total protein was extracted from 2 dpf embryos 
and electrophoresed through a 12.5 % polyacrylamide SDS 
gel. Protein was transferred to a nitrocellulose membrane 
and probed with either; anti-α-actin (Sigma clone A2066, 
1:400) or β-tubulin (1:5000, Millipore). Secondary HRP 
antibodies were all used at 1:5000 (Chemicon).
Swimming assays
Touch-evoked response assays were performed at 2 dpf. 
Zebrafish larvae were imaged using a high-speed infrared 
camera (1000 frames per second) following a gentle tap 
of the head using a blunt needle. The maximum accelera-
tion of the fish was extracted using the ZebraLab software 
(ViewPoint Life Sciences) with a low detection threshold 
of 6 mm/s. The Tg(actc1b-eGFP) zebrafish line was used 
as a control.
Locomotor activity was examined at 6 dpf by recording 
the larval activity and swimming distance during a 10-min 
period using a Zebrabox (ViewPoint Life Sciences). Lar-
vae were gently pipetted into 48-well plates and allowed 
to habituate in the light for 5 min before the experiment 
started. Using a high-speed infrared camera (25 frames 
per second), the embryos were tracked in the dark for 
10 min with the following parameters: inactivity thresh-
old of 6 mm/s, detection threshold of 25 mm/s, and activ-
ity burst threshold of 30 mm/s. Both the number of small 
movements (above inactivity threshold and below activity 
burst threshold) and total distance swum in a 10-min period 
were extracted using the ZebraLab software (ViewPoint 
Life Sciences). The Tg(actc1b-eGFP) zebrafish line was 
used as a control.
Statistics
For statistical analysis, a Student’s t test assuming equal 
variance was used to determine significance and performed 
using Excel (Microsoft) and graphs were prepared in Prism.
Results
Overexpression of ACTA1D286G‑eGFP in zebrafish 
recapitulates the nemaline myopathy phenotype
We created a conditional transgenic zebrafish model for 
ACTA1 nemaline myopathy, Tg(ACTA1D286G-eGFP) that 
expresses human ACTA1D286G in skeletal muscles. The 
Tg(ACTA1D286G-eGFP)high fish recapitulate hallmark patho-
logical features of the disease with the presence of nema-
line bodies in skeletal muscles at 48 and 72 hpf (Supple-
mentary Figure S1). In addition to the trunk musculature, 
other striated muscles such as the facial, heart, and ocular 
muscles also contained numerous nemaline bodies (Fig. 1). 
At 72 hpf, we observed aggregates at the myosepta. These 
aggregates differ in appearance to the earlier-forming 
nemaline bodies, having a globular appearance rather than 
a clear and defined rod shape (Supplementary Figure S1).
Gomori trichrome staining of skeletal muscle dem-
onstrated the presence of patches of intense purple stain-
ing, indicative of nemaline bodies, correlating with eGFP 
expression (Fig. 2a). Immuno-CLEM analysis revealed 
densely stained nemaline bodies that correlated with the 
eGFP-positive structures observed by confocal micros-
copy (Fig. 2b). Using conventional electron microscopy 
on Tg(ACTA1D286G-eGFP) zebrafish, we also observed 
filamentous actin accumulations adjacent to the sarcomere 
and, occasionally, the sarcomeres appeared disorganized 
compared to those in Tg(ACTA1-eGFP) zebrafish (Fig. 2c).
Nemaline bodies are highly dynamic and transitory 
in Tg(ACTA1D286G‑eGFP) fish
To investigate the origins of the nemaline bodies within 
the cell, we carried out in vivo time-lapse analysis of the 
Tg(ACTA1D286G-eGFP)high fish. This showed, for the 
first time, that nemaline bodies form at the sites of mus-
cle attachment at approximately 30 hpf and then extended 
into the muscle cell (Fig. 3a, Supplementary Movie S1). As 
development progressed, the nemaline bodies were seen to 
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move throughout the cytoplasm (Fig. 3a, Supplementary 
Movie S1). The nemaline bodies were highly dynamic, 
rather than being tethered to the Z-disk or extracellular 
matrix as previously proposed [46, 57]. By 60 hpf, the 
characteristic rod-like bodies fragmented and disappeared 
from the cell, coincident with the formation of the globu-
lar aggregates at the myosepta (Fig. 3a, Supplementary 
Movie S2). Indeed time-lapse analysis of Tg(ACTA1D286G-
eGFP)high fish showed that as nemaline bodies’ fragment, 
the fluorescent fusion protein previously incorporated 
within them can be encapsulated into globular aggregates, 
at the myosepta (Fig. 3a, Supplementary Movie S2).
In addition to the Tg(ACTA1D286G-eGFP)high zebrafish 
strain that showed high ACTA1D286G-eGFP expression, we 
also constructed a Tg(ACTA1D286G-eGFP) low-expressing 
strain (Tg(ACTA1D286G-eGFP)low; Fig. 4b). We analyzed 
the frequency of nemaline bodies during early larval stages 
in both transgenic strains. We observed almost no nemaline 
bodies in the Tg(ACTA1D286G-eGFP)low strain correlating 
with the much lower level of ACTA1D286G-eGFP expression 
(Figs. 3b, 4b). Contrastingly, the Tg(ACTA1D286G-eGFP)high 
strain showed the presence of nemaline bodies at 2 dpf, fol-
lowed by a dramatic reduction at 4 dpf (Fig. 3b). Quanti-
fication of the aggregate phenotype identified an increase 
in the percentage of fish developing globular aggregates in 
skeletal muscle at 4 dpf, coincident with the disappearance 
of nemaline bodies (Fig. 3c). This supports the suggestion 
that early forming nemaline bodies may be one source of 
the ACTA1 that forms the globular aggregates.
To determine if the different aggregates could be dis-
tinguished immunologically, we performed antibody and 
phalloidin (labeling F-actin) staining on zebrafish muscle 
Fig. 1  Nemaline bodies form in skeletal muscle in Tg(ACTA1D286G-
eGFP)high zebrafish. Nemaline bodies were detected in a skeletal 
muscle (arrowheads) and pectoral fins (arrow) (i and ii overlaid with 
brightfield), b heart (arrowheads) (i and ii overlaid with brightfield), 
c facial muscles (arrowheads) (i and ii overlaid with brightfield) and 
d ocular muscles (arrowheads; i and overlaid with ii brightfield)
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expressing ACTA1D286G-eGFP. Although nemaline bodies 
could be detected at 2 dpf using an antibody against eGFP, 
they were not detected by Actinin2 or Actinin3 antibodies, 
nor by phalloidin (Fig. 5a, Supplementary Figure S2). In 
contrast, the globular aggregates at 4 dpf were positive for 
Actinin2, Actinin3 and phalloidin (Fig. 5a, Supplementary 
Figure S2). We also co-expressed the cardiac α-actin cDNA 
fused with mCherry (actc1a-mCherry) together with ACT-
A1D286G-eGFP in the skeletal muscle and showed that both 
types of aggregates incorporated cardiac actin (Supplemen-
tary Figure S2). To determine if similar α-actinin-negative 
nemaline bodies were present in patients with mutations 
Fig. 2  Characterization of skeletal muscle pathology in 
Tg(ACTA1D286G-eGFP)high zebrafish. a Skeletal muscle expressing 
i mosaic ACTA1D286G-eGFP, and ii overlaid with a light microscopy 
image of the same section showing Gomori trichrome staining, and 
iii enlarged. Dark regions (indicative of nemaline bodies) of disrupted 
muscle correspond to eGFP expression (arrows). b Correlative light 
and electron microscopy of Tg(ACTA1D286G-eGFP)high fish muscle at 
2 dpf. b i Fluorescent image and corresponding ii electron micros-
copy image of skeletal muscle section containing a dense, elongated 
nemaline body (arrow) and enlarged in (iii). Sections are matched 
using nuclei positions (asterisk, plus and hash). c i Accumulations 
of actin filaments (arrowheads) and ii diffuse regions of filamentous 
actin (arrowheads), as well as ii disrupted sarcomeric regions are evi-
dent in Tg(ACTA1D286G-eGFP)high skeletal muscle, at 2 dpf unlike the 
iii uniform sarcomeres observed in Tg(ACTA1-eGFP) zebrafish
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in ACTA1, we tested patient skeletal muscle biopsies. As 
observed in Tg(ACTA1D286G-eGFP)high zebrafish, we found 
that nemaline bodies can exhibit different protein signa-
tures. In a biopsy from a patient with a T66I mutation in 
ACTA1 [18], nemaline bodies darkly stained by Gomori 
trichome are both phalloidin and actinin2 positive (Fig. 6). 
Whereas for a patient with an I136M mutation in ACTA1 
[18], nemaline bodies darkly stained by Gomori trichome 
are phalloidin positive and either actinin2 positive or nega-
tive (Fig. 6). 
Cytoplasmic actin aggregates correlate with reduced 
skeletal muscle function
Using time-lapse analysis, we observed the formation of 
globular aggregates in the skeletal muscle and hypoth-
esize that these may contribute to muscle weakness. To 
test this, we overexpressed a human wild-type ACTA1 
eGFP-tagged transgene in the zebrafish skeletal mus-
cle (Supplementary Figure S1). We constructed trans-
genic strains with high and low levels of ACTA1wildtype-
eGFP expression (Tg(ACTA1wildtype-eGFP)high and 
Tg(ACTA1wildtype-eGFP)low, respectively) (Fig. 4b). In 
contrast to the rod-shaped nemaline bodies observed 
in Tg(ACTA1D286G-eGFP)high fish, expression of ACT-
A1wildtype-eGFP never induced the formation of rod-
like structures (Supplementary Movie S3). Rather, 
Tg(ACTA1wildtype-eGFP)high fish only produced globular 
aggregates that formed at the myosepta and showed an 
identical immunological signature to those observed in 
Tg(ACTA1D286G-eGFP)high fish (Fig. 5, Supplementary Fig-
ure S2). This demonstrates that globular aggregates are a 
result of increased ACTA1 and not specifically caused by 
the ACTA1D286G mutation. These globular aggregates were 
formed at earlier developmental stages in Tg(ACTA1wildtype-
eGFP)high fish (Supplementary Movies S3 and S4) com-
pared to Tg(ACTA1D286G-eGFP)high fish (Supplementary 
Movie S2).
To assess the pathogenicity of globular aggregates in 
the skeletal muscle, we examined muscle function in both 
Tg(ACTA1wildtype-eGFP) and Tg(ACTA1D286G-eGFP) trans-
genic strains at 2 and 6 dpf. Using a touch-evoked escape 
response assay, we were able to determine the maximum 
acceleration of 2 dpf larvae as a direct measure of muscle 
Fig. 3  Formation of nemaline bodies and aggregates in 
Tg(ACTA1D286G-eGFP)high zebrafish. a Maximum projection images 
from time lapse of Tg(ACTA1D286G-eGFP)high fish from 56 to 71 hpf 
showing nemaline bodies distributed throughout the skeletal muscle 
(arrows). Nemaline bodies’ fragment from 59.5 hpf (arrows), coin-
cident with the formation of aggregates at the myosepta (arrow-
heads). b Quantification of the mean number of nemaline bodies in 
Tg(ACTA1D286G-eGFP)low (n = 50 per stage) and Tg(ACTA1D286G-
eGFP) (n = 48 per stage) strains. c Quantification of the percentage 
of fish displaying globular aggregates in Tg(ACTA1D286G-eGFP)low 
and Tg(ACTA1D286G-eGFP)high strains (n = 50 per stage). Error bars 
represent SEM from three independent experiments (n = 45 per rep-
licate)
396 Acta Neuropathol (2015) 130:389–406
1 3
force. We found a significant decrease in the maximum 
acceleration of both Tg(ACTA1wildtype-eGFP)high and 
Tg(ACTA1D286G-eGFP)high compared to control zebrafish, 
demonstrating that cytoplasmic actin is pathogenic 
(Fig. 4a). We also recorded the swimming performance 
at 6 dpf and observed a significant decrease in the num-
ber of movements and in the distance traveled by both 
Tg(ACTA1wildtype-eGFP)high and Tg(ACTA1
D286G-eGFP)high 
strains compared to controls (Fig. 4d).
In addition, we assayed the activity of the low-express-
ing zebrafish strains. While the swimming abilities of 
Tg(ACTA1wildtype-eGFP)low fish were comparable to control 
fish, Tg(ACTA1D286G-eGFP)low fish displayed significantly 
reduced swimming at 6 dpf (Fig. 4c, d). This reduction in 
swimming activity correlated with the level of transgene 
expression (Fig. 4b). These findings demonstrate that cyto-
plasmic actin aggregates correlate with reduced skeletal 
muscle performance.
We next examined a model of nemaline myopathy 
resulting from a loss of Neb to determine whether actin 
aggregates were a common feature associated with nema-
line myopathy. We injected two neb splice-site-targeting 
morpholinos (both singularly and in combination) into 
wild-type zebrafish. The efficacy of the morpholinos was 
Fig. 4  Quantification of muscle function in Tg(ACTA1-eGFP) 
zebrafish. a Quantification of the maximum acceleration recorded 
from touch-evoked response assays of Tg(ACTA1D286G-eGFP)high and 
Tg(ACTA1wildtype-eGFP)high zebrafish compared to control zebrafish at 
2 dpf. Error bars represent SD for n = 15–19 zebrafish, *p < 0.05. b 
qRT-PCR analysis of ACTA1-eGFP expression in transgenic lines at 2 
dpf. No significant difference was observed between Tg(ACTA1D286G-
eGFP)high and Tg(ACTA1
wildtype-eGFP)high zebrafish. Error bars 
represent ±SEM for four replicate experiments with each experi-
ment comprising a pooled samples of 20 fish, *p < 0.05, **p < 0.01. 
c, d Quantification of the c number of small movements and d dis-





eGFP)low strains compared to control fish at 6 dpf. Error bars 
represent ±SEM for three replicate experiments (n = 48 per experi-
ment), *p < 0.05, **p < 0.01
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confirmed by qRT-PCR showing that neb mRNA levels 
are reduced by approximately 80 % by each morpholino 
and approximately 90 % when both morpholinos are used 
in combination (Fig. 7b, c). The effect on Neb was fur-
ther confirmed by examining sarcomere length, with Neb 
morphants (Fig. 8a) displaying significantly shorter sar-
comere lengths compared to controls (Fig. 7d, e).
When neb morpholinos were injected singularly and 
in combination into both the high- and low-express-
ing Tg(ACTA1wildtype-eGFP) strains we observed an 
Fig. 5  Characterization of nemaline bodies and aggregates in 
ACTA1-eGFPD286G muscle in zebrafish. At 2 dpf, mosaic expres-
sion of ACTA1D286G-eGFP in the muscle (green) results in the for-
mation of nemaline bodies (arrows; i, iv, vii) that do not stain with 
an actinin2 antibody (red; ii and overlaid in iii), actinin3 antibody 
(red; v and overlaid in vi), or phalloidin (labeling F-actin, red; viii 
and overlaid in ix) despite correct localization of these markers in the 
sarcomere. At 4 dpf, mosaic expression of ACTA1D286G-eGFP results 
in the formation of globular aggregates (arrowheads; i, iv, vii) in the 
muscle (green) stain with an actinin2 antibody (red; ii and overlaid in 
iii), actinin3 antibody (red; v and overlaid in vi) and phalloidin (red; 
viii and overlaid in ix)
Fig. 6  Characterization of nemaline bodies in patient muscle biop-
sies. In ACTA1T66I muscle, nemaline bodies (white arrowheads), 
darkly stained by Gomori trichome, are positive for actinin2 and 
phalloidin (labeling F-actin). In ACTA1I136M muscle, nemaline bod-
ies are phalloidin positive and actinin2 positive (yellow arrowheads) 
or actinin2 negative (gray arrowheads). Control (unaffected) mus-
cle shows normal localization of markers in the absence of nemaline 
bodies
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increase in eGFP-positive accumulations at the myosepta 
(Fig. 8a). These accumulations were also phalloidin posi-
tive (Fig. 8b), akin to those observed in Tg(ACTA1D286G-
eGFP)high and Tg(ACTA1
wildtype-eGFP)high zebrafish, and 
were not observed in control embryos.
Loss of α‑actin results in Actinin2 accumulation 
and reduced skeletal muscle function
Our analysis has shown that overexpression of ACTA1D286G 
produces nemaline bodies and causes detrimental effects 
on muscle function. However, nemaline bodies have been 
reported in patients carrying recessive ACTA1 mutations 
leading to an absence of skeletal muscle α-actin protein. 
Skeletal muscle biopsies from these patients contain dis-
organized myofibrils and nemaline bodies, presumably 
caused by an imbalanced stoichiometry between sarcom-
eric components [32].
Using our zebrafish system, we also created a model 
for recessive nemaline myopathy. Zebrafish possess two 
skeletal muscle α-actin genes (acta1a and acta1b) and 
two cardiac α-actin genes (actc1a and actc1b), which are 
all expressed during early muscle development. qRT-PCR 
analyses showed that actc1b is the predominant isoform 
expressed in the skeletal muscle at 2 dpf (Fig. 9a). Thus, 
we chose to knockdown Actc1b to reduce the amount of 
α-actin in skeletal muscle.
We injected two morpholinos (one targeting the exon 
2 splice donor site and one targeting the 5′UTR). We 
observed a reduction in α-actin protein by approximately 
43 % (Fig. 9b, c) along with decreased phalloidin stain-
ing in Actc1b morphants compared to control zebrafish 
(Fig. 10). Morphologically, Actc1b morphants (Fig. 11a) 
display impaired skeletal muscle function, showing a 
reduction in both maximum acceleration at 2 dpf and in 
swimming distance at 6 dpf (Fig. 11b, c).
Fig. 7  Analysis of nebulin knockdown in zebrafish muscle. a Bright-
field and fluorescent images of wild-type embryos injected with two 
different nebulin (neb)-targeting morpholinos (MOs) compared to 
control uninjected embryos at 2 dpf. Successful injection is confirmed 
by the presence of Cascade Blue (CB) labeling. b qRT-PCR analysis 
showing significant knockdown of neb transcript in Neb morphants 
compared to control uninjected (control) at 2 dpf. Error bars repre-
sent ±SEM for three replicate experiments with each experiment 
comprising a pooled samples of 20 fish, *p < 0.05. c RT-PCR anal-
ysis revealed the absence of correctly spliced, and presence of mis-
spliced, neb transcript in Neb ex5 morphants compared to control 
uninjected (cont) and reduced expression of neb transcript in Neb ex 
35 morphants at 2 dpf. β-actin was used as an amplification control. 
d Quantification of sarcomere lengths showed a significant decrease 
in neb morphants compared to controls at 2 dpf. Error bars repre-
sent ± SEM for four replicate experiments (n = 10 per experiment), 
*p < 0.01. e Actinin2 labeling of Z-disks in morphant and control 
zebrafish at 2 dpf illustrates the reduced sarcomere length in Nebulin 
morphants compared to controls over 10 sarcomeres (represented by 
the distance between the black arrow and red arrows)
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EM analyses revealed the presence of electron-dense 
projections extending from the myosepta (Fig. 12). 
Thickened Z-disks were clearly evident and in some 
cases the electron-dense region appeared to span the 
full width of a sarcomere (Fig. 12). We also observed 
disorganized and broken myofibrils surrounded by 
large numbers of mitochondria in the Actc1b morphant 
skeletal muscle compared to control skeletal muscle 
(Fig. 12). We performed antibody and phalloidin stain-
ing on the skeletal muscle and identified phalloidin- and 
Actinin2-positive nemaline bodies, concentrated near the 
myosepta, as well as Actinin2-positive aggregates and 
thickened Z-disks throughout the myofibrils in Actc1b 
morphants that are not present in the control skeletal 
muscle (Fig. 10).
We injected the actc1b morpholino into the 
Tg(ACTA1wildtype-eGFP)low strain and analyzed the results 
using in vivo time-lapse imaging. We showed that unlike 
early forming nemaline bodies in Tg(ACTA1D286G-eGFP) 
muscle, these nemaline bodies were stable in the skeletal 
muscle, forming from 32 hpf. They were located both at the 
myosepta and scattered throughout the muscle fibers (Sup-
plementary Movie S5) and were not observed in control 
embryos (Supplementary Movie S6).
Fig. 8  a Maximum projection confocal microscopy images of 
Tg(ACTA1wildtype-eGFP)low and Tg(ACTA1
wildtype-eGFP)high zebrafish 
strains injected with two different Nebulin (Neb) morpholinos com-
pared to control uninjected embryos at 2 dpf. There is an increased 
prevalence of eGFP-positive globular aggregates at the myosepta 
(arrowheads) in Tg(ACTA1wildtype-eGFP)high Neb morphants com-
pared to controls. Knockdown of Neb produces globular aggregates 
at the myosepta (arrowheads) in Tg(ACTA1wildtype-eGFP)low Neb 
morphants that are absent in control uninjected embryos. b Maximum 
projection confocal microscopy images of wild-type embryos injected 
with Neb morpholinos at 2 dpf and stained with phalloidin shows an 
increase in actin-positive aggregates at the myosepta (arrowheads), 
which are absent in control uninjected embryos
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ACTA1D286G is mislocalized and more rapidly 
exchanged in the sarcomere
We showed that an imbalance of actin levels in the skel-
etal muscle results in aggregates and muscle weakness. 
However, we also wanted to determine whether over-
expression of ACTA1-eGFPD286G has an additional, 
mutation-specific, effect in the skeletal muscle. Previ-
ous studies have suggested that ACTA1D286G may have 
a reduced ability to polymerize and be incorporated into 
Fig. 9  a) qRT-PCR analysis of skeletal α-actin genes in zebrafish 
tail muscle at 2 dpf. Error bars represent ±SEM for three replicate 
experiments with each experiment comprising a pooled samples of 20 
fish, *p < 0.01. b, c The decrease in total amount of α-actin protein in 
Actc1b (ex 2 and UTR) morphants at 2 dpf was confirmed and quan-
titated by Western blot. β-tubulin was used as a loading control
Fig. 10  Maximum projection confocal microscopy images of Actc1b 
morphants and control zebrafish stained with phalloidin at 2 dpf or 
with an actinin2 antibody at 2 dpf and 6 dpf. Actinin2 and phalloidin-
positive nemaline bodies are observed throughout the muscle fibers 
(arrows) as well as projecting from the myosepta (arrowheads) in 
Actc1b morphants compared to controls
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the sarcomere [7, 49]. To examine the dynamics of ACT-
A1D286G in Tg(ACTA1D286G-eGFP)high zebrafish, we per-
formed FRAP analysis on both the thin filament and the 
Z-disk at 2 dpf. We found a significant reduction in the 
average time taken for 50 % recovery at both locations fol-
lowing photobleaching for ACTA1D286G-eGFP (filament: 
22.74 ± 10.22 s, Z-disk: 52.38 ± 9.19 s) compared to 
Tg(ACTA1wildtype-eGFP)high fish (filament: 106.7 ± 34.6 s,: 
Z-disk: 85.79 ± 16.71 s) (Fig. 13c). This showed that the 
ACTA1D286G protein is readily incorporated into the sar-
comere, but is more rapidly exchanged at both the Z-disk 
and thin filament than ACTA1wildtype, suggesting it may be 
less stably associated.
During the FRAP analysis, we observed that the locali-
zation of the two proteins within the sarcomere differed. 
While the ACTA1wildtype-GFP protein demonstrated a 
clear striated pattern, with well-defined Z-disk structures, 
ACTA1D286G-eGFP showed more generalized distribution 
throughout the length of the thin filament (Fig. 13a). We 
quantified this difference by comparing the fluorescence 
intensity of the Z-disk to the rest of the filament in both 
Tg(ACTA1D286G-eGFP)high and Tg(ACTA1
wildtype-eGFP)high 
fish. We found a significant decrease in the ratio of Z-disk/
filament eGFP intensity in Tg(ACTA1D286G-eGFP)high 
(1.3 ± 0.07) compared to Tg(ACTA1wildtype-eGFP)high 
(1.6 ± 0.1) fish. This finding suggested that ACTA1D286G is 
preferentially localized along the thin filament (Fig. 13b).
Discussion
We describe the generation of zebrafish ACTA1 nemaline 
myopathy models allowing us to investigate disease patho-
genesis in vivo. Utilizing the advantages of the zebrafish 
system we analyze, for the first time, nemaline body 
formation and dynamics in vivo. Through the overexpres-
sion of an eGFP-tagged ACTA1 variant or knockdown of 
α-actin in the skeletal muscle, we observed the formation 
of three distinct types of nemaline bodies. ACTA1D286G 
expression resulted in the formation of actinin-negative 
nemaline bodies at the myosepta, whereas reduction of 
actin resulted in Z-disk thickening and nemaline bodies 
within the myofibril and the formation of Actinin2-positive 
nemaline bodies at the myosepta.
We found that the early forming nemaline bodies in 
Tg(ACTA1D286G-eGFP)high fish are highly dynamic within 
the cell This is both spatially, with nemaline bodies form-
ing close to the myosepta before moving rapidly through-
out the cytoplasm, and temporally, as they form around 
48 hpf and degrade by 96 hpf. The transitory nature of the 
nemaline bodies may explain why there is no correlation 
between their frequency and disease severity [17, 44]. Fol-
lowing the breakdown of the nemaline bodies, we observe 
the formation of actin-positive globular aggregates. Swim-
ming behavior at 6 dpf, following the transition from nema-
line bodies to globular actin aggregates was impaired, 
suggesting that cytoplasmic actin accumulation may be 
detrimental to muscle function.
To test this, we created a line overexpressing the wild-
type form of ACTA1. Tg(ACTA1wildtype-eGFP)high fish 
formed globular aggregates, in the absence of nemaline 
bodies and had reduced muscle performance, indicating 
that these aggregates likely contribute to reduced skeletal 
muscle function. Intriguingly, the earlier detection of the 
aggregates in the Tg(ACTA1wildtype-eGFP)high fish rather 
than in the Tg(ACTA1D286G-eGFP)high suggests that the 
nemaline bodies might delay the formation of these aggre-
gates, most likely through the sequestration of actin. The 
nemaline bodies may therefore be part of a protective 
mechanism as suggested for intranuclear rod myopathy [8], 
Fig. 11  Functional analysis of Actc1b knockdown in zebrafish. a 
Brightfield images of wild-type embryos injected with actc1b tar-
geting morpholinos (MO) compared to control uninjected embryos. 
b Quantification of the maximum acceleration recorded from touch-
evoked response assays of Actc1b morphants compared to con-
trol zebrafish at 2 dpf. Error bars represent SEM for three replicate 
experiments (20 fish per replicate), **p < 0.01. c Quantification of the 
distance traveled by Actc1b morphants compared to control zebrafish 
at 6 dpf. Error bars represent ±SEM for three replicate experiments 
(n = 48 per experiment), **p < 0.01
402 Acta Neuropathol (2015) 130:389–406
1 3
and by the observation of rod formation in wild-type mus-
cle under conditions of extreme stress [29].
As our experimental system overexpressed ACTA1, we 
examined a model of recessive nemaline myopathy to see if 
similar cytoplasmic actin aggregates were present. Examin-
ing Neb morphant embryos, we identified a shortening of 
the sarcomere length as observed in NEB-deficient animal 
models [4, 36, 48] and NEB-related nemaline myopathy 
patients carrying deletions in exon 55 [37]. Neb morphants 
also displayed accumulations of globular cytoplasmic actin 
aggregates comparable to those identified in the ACTA1 
models, suggesting this may be a common phenotype in 
the disease, despite a different genetic cause. Recent data 
have demonstrated an increase in F-actin accumulation, 
coupled with increased expression of α-actin isoforms in 
Cfl2 knockout mice [2, 14] and in patients carrying CFL2 
mutations [1]. Furthermore, it has recently been shown 
that loss of KLHL40 causes a reduction in NEB, leading to 
destabilization of the thin filament [11] and increased actin 
was observed in patients with mutations in KLHL40 [43]. 
Together with our data, this suggests that the accumulation 
of actin in the cytoplasm is one of the contributing factors 
to reduced muscle performance in nemaline myopathy.
However, the formation of nemaline bodies can not 
only be caused by the presence of mutant actin, and nei-
ther can the accumulation of actin in the cytoplasm be the 
sole cause of muscle weakness, since loss of ACTA1 also 
results in the disease [32]. We therefore examined the 
Fig. 12  Electron microscopy images of Actc1b ex 2 morphants 
at 2 dpf showing ii electron-dense projections emanating from the 
myosepta (arrowheads) as well as nemaline bodies derived from v 
thickened Z-disks throughout the fibers not observed in control fish (i, 
iii). Sections also contained broken muscle fibers iv as well as numer-
ous mitochondria (black arrowheads; iv), compared to the uniform 
sarcomeres in control zebrafish skeletal muscle iii
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consequence of reducing actin in the skeletal muscle. We 
used two different morpholinos to reduce actin levels in 
the skeletal muscle, both of which resulted in the forma-
tion of two further forms of Actinin2-rich nemaline bod-
ies. One originated in the cytoplasm, in the vicinity of the 
myosepta, and the other appeared to form from Z-disk 
thickenings that expanded to engulf an entire sarcomere. 
The cytoplasmic Actinin2-rich aggregates were also posi-
tive for actin, suggesting they further deplete the sarcom-
eric pool of actin, and may impair muscle function in this 
way. The electron-dense material engulfing the sarcomere 
would be expected to form a non-contractile region in the 
fiber reducing function. EM analyses showed that these 
sarcomeric nemaline bodies were concentrated around 
regions of fiber disorganization and dissolution, suggest-
ing that their presence interferes with normal sarcomere 
function causing an inherent structural weakness. This is 
consistent with a recent analysis of muscle biopsies from 
NEB-related nemaline myopathy patients that showed 
myofibrillar dissociation appeared to be an important 
cause of muscle weakness rather than the frequency or 
position of nemaline bodies within muscle fibers, which 
inversely correlated with severity [28]. Functional analysis 
of Actc1b morphants demonstrated significantly reduced 
skeletal muscle function at both 2 dpf and 6 dpf, pro-
portional to the loss of α-actin in the skeletal muscle. In 
Actc1b morphants, we observed electron-dense projec-
tions extending from the myosepta, a structure analogous 
to the myotendinous junction. While disruptions to the 
myotendinous junction are not thought to be common in 
patients with ACTA1 mutations, the recessive ACTA1V154L 
mutation results in a dystrophic phenotype, alongside 
Fig. 13  Fluorescence recovery after photobleaching (FRAP) analy-
ses of ACTA1 and ACTA1D286G. a Confocal images of ACTA1-eGFP 
localization at the Z-disk (white boxes) and along the thin filament 
(yellow boxes) in single muscle fibers of Tg(ACTA1D286G-eGFP)high 
and Tg(ACTA1wildtype-eGFP)high embryos at 2 dpf. Image sequence 
shows ACTA1-eGFP prior to photobleaching (pre-bleach), at the 
time of photobleaching (bleach, 0 s), and 60, 300 and 600 s following 
photobleaching. Prior to photobleaching eGFP in Tg(ACTA1wildtype-
eGFP)high muscle is primarily localized to the Z-disk (white boxes), 
whereas in Tg(ACTA1D286G-eGFP)high fibers, eGFP expression is 
more diffuse throughout the filament (yellow boxes). b Quantification 
of the fluorescence intensity at the Z-disk compared to the filament 
in Tg(ACTA1D286G-eGFP)high and Tg(ACTA1
wildtype-eGFP)high muscle 
fibers. Error bars represent SD for 12 animals (quantifying 2 fibers 
per animal), ***p < 0.001. c Recovery profiles for ACTA1-eGFP and 
ACTA1D286G-eGFP at the Z-disk and filament. Error bars represent 
SD for 8–10 animals (quantifying 2 fibers per animal)
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Z-disk streaming and infrequent nemaline bodies [33], 
consistent with dystrophic disruption to this structure.
The frequent presence of Z-disk thickening in nema-
line myopathy has led to the prevalent theory that nema-
line bodies originate from, and are tethered to, the Z-disk 
[9, 40, 41, 57]. Our observations show that only one of 
the three types of nemaline bodies originates within the 
Z-disk. This is supported by reports of nemaline patients 
with nemaline bodies but without Z-disk thickening [46] 
and the observation of nemaline bodies in proximity to the 
myotendinous junction. The subtypes of nemaline bodies 
we identified in the zebrafish can be distinguished immu-
nologically. To determine if the same was true in patients, 
we examined muscle biopsy samples from ACTA1 nema-
line myopathy patients and also found variations in phal-
loidin and actinin2 labeling of nemaline bodies. In ACT-
A1T66I muscle biopsy samples, nemaline bodies contained 
both phalloidin and actinin2. However, in ACTA1I136M, 
both actinin2-positive and -negative nemaline bodies were 
identified, confirming previous reports in cell culture [12, 
18, 50], and likely corresponding to those identified in the 
fish. The different composition of the nemaline bodies may 
allow the subtypes to be used as indicators of the mecha-
nism triggering nemaline body formation and potentially 
aid in the identification of the causative mutation. Further 
support for the formation of different types of nemaline 
bodies comes from examining other nemaline myopathies, 
such as those caused by a CFL2 mutation, which have iden-
tified a mixture of aggregates, some that stained for F-actin 
and actinin2, and others that did not [1]. It should be noted 
that despite the lack of phalloidin labeling, these nemaline 
bodies in our ACTA1D286G model fish contain actin. The 
lack of labeling therefore reflects differences in the confor-
mation of actin in the bodies, compared to sarcomeres, pre-
venting binding of phalloidin.
Both our overexpression and loss-of-function ACTA1 
nemaline myopathy models show that actin imbalance in 
the skeletal muscle has pathogenic consequences. In addi-
tion to the formation of nemaline bodies and actin aggre-
gates, ACTA1 mutation can also directly affect its sarco-
meric function. The ACTA1D286G mutation lies near the 
hydrophobic pocket, which is important for actin–actin 
interactions [16]. Due to this location, and the reduced 
incorporation of ACTA1D286G into actin filaments reported 
in myoblasts, it has been suggested that the polymerization 
of ACTA1D286G could be impaired [5]. We directly exam-
ined actin dynamics identifying a more rapid exchange of 
ACTA1D286G compared to ACTA1wildtype protein. Although 
the mutant actin was incorporated into the sarcomere, we 
identified a reduced affinity for the Z-disk and increased 
affinity for the thin filament. These changes in dynamics 
and sub-sarcomeric localization, coupled with a reduction 
in binding strength at the actomyosin interface [34], will 
impact thin filament function in the sarcomere, leading 
to muscle weakness. Similarly, mutation-specific contri-
butions to muscle weakness are observed in NEB-related 
nemaline myopathy, where altered thin filament lengths 
reduce muscle contractile performance [37, 38].
Our study identifies multiple subtypes of nemaline bod-
ies and characterizes, in vivo, their origin within the skel-
etal muscle. We demonstrate that these subtypes can be 
differentiated immunologically in skeletal muscle biopsies 
from ACTA1 nemaline myopathy patients, potentially pro-
viding markers for disease severity and aiding in the iden-
tification of the causative mutation. We further identify 
accumulation of cytoplasmic actin, myofibrillar disarray, 
sarcomeric disruption, and actin depletion as contribu-
tors to muscle weakness. Our analysis of a NEB-related 
nemaline myopathy model and data from other forms of 
nemaline myopathy suggest that these mechanisms may 
be common across nemaline myopathy. Furthermore, the 
generation of these zebrafish models has additionally estab-
lished an ideal platform for the development and evaluation 
of therapies.
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